Lyndra Therapeutics
高管
查看带有其 15 名主要高管的组织结构图
Lyndra Therapeutics 搜索最多的简介
- Jessica Ballinger, President and Chief Executive Officer
- Giovanni Traverso, Director
- Eric Trac, Director
创建提醒
跟踪 Lyndra Therapeutics 的高管变动
生物技术
Lyndra Therapeutics 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Lyndra Therapeutics 的最新新闻稿
- Lyndra Therapeutics Backstage at BIO 2024 - Lyndra
- Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia
- Lyndra Therapeutics Raises $101 Million in Series E Funding
- Long-lasting oral therapy developer Lyndra secures a $101m Series E - Pharmaceutical Technology
- Ballinger at the helm at Lyndra
- Lyndra Therapeutics Announces Leadership Changes, Update on Pivotal Trial Progress
- Lyndra Therapeutics Presents Data on Long-Acting Oral Weekly Risperidone (LYN-005) at American Society of Clinical Psychopharmacology 2023 Annual Conference
- 20 Important Quotes That Can Change Your Company’s Culture
- Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder
- Dr. Patricia Hurter - LifeSci Voice
- View more press releases Close
通过电子邮件
